Skip to content

To check for neonatal infections using saliva

Pilot study to identify potential saliva-based biomarkers for diagnosis of neonatal sepsis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/04/008427
Enrollment
100
Registered
2017-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- neonates, showing clinical symptoms for sepsis

Interventions

None listed

Sponsors

Spot Healthcare Solutions Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The inclusion criteria will include all neonate who show clinical symptoms for sepsis (i.e any two of the following symptoms: respiratory distress, temperature fluctuation, diarrhea, reduced movements, reduced sucking, seizures, bradycardia, swollen belly area, heart rate >160). A hematological sepsis screen (as per section 8.4.2) and blood culture will be conducted. The obtained sample groups will be categorized in following sections 1. Serum samples showing positive results for sepsis screen and positive results for blood culture 2. Serum samples showing positive results for sepsis screen but negative results for blood culture Diagnosis of sepsis will be confirmed for neonates showing positive result for sepsis screen and a positive result for blood culture. CONTROL GROUP: 50 age and sex matched healthy neonates (showing no clinical symptom for sepsis) will be recruited as the control group for this study.

Exclusion criteria

Exclusion criteria: Neonates who exhibit clinical symptoms for or have been identified with the following will be excluded from this study 1. Congenital malformation 2. Intraventricular bleed 3. Chronic lung disease 4. Perinatal asphyxia 5. Meconium aspiration syndrome 6. Chromosomal malformations

Design outcomes

Primary

MeasureTime frame
Positive predictive value and negative predictive value of potential biomarkers for neonatal sepsis.Timepoint: August 2017

Secondary

MeasureTime frame
Biomarker detection based point-of-care test for neonatal sepsis screening.Timepoint: December 2017

Countries

India

Contacts

Public ContactDr Kishore R Kumar

Kids Clinic India Pvt. Ltd (Cloudnine Hospital)

drkishore@cloudninecare.com9900155001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026